P
Protagenic Therapeutics, Inc. (PTIX)
OQB – Real Time Price. Currency in USD
0.48
-0.17 (-25.54%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
OQB – Real Time Price. Currency in USD
0.48
-0.17 (-25.54%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $4.0M significantly exceeds cash reserves ($2.2M), raising financial stability concerns
Total current liabilities $6.8M surpass Total current assets $2.3M, signaling liquidity issues
Debt-to-equity ratio (-1.7) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$509.7K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.34 | 6.05 | 3.0 | |
| Quick ratio | 0.34 | 5.63 | 3.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.90 | 1.04 | 2.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 2.0 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | -30 | -28K | -50K | -50K |
| Operating Income | -4M | -4M | -5M | -6M | -6M |
| Net Income | -5M | -4M | -5M | -6M | -5M |
| EBITDA | -4M | -4M | -4M | -6M | -6M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 354.26 | N/A | 63.47 | 7.8 |
| Y/Y | 999 | 445.01 | N/A | -174.51 | 5.5 |
| 3y average | 999 | -9.9 | N/A | -24.59 | 3.3 |
| 5y average | 999 | -30.54 | N/A | -71.53 | 3.3 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |